Cargando…

Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer

Detalles Bibliográficos
Autores principales:	Moufarrij, Sara, Srivastava, Aneil, Gomez, Stephanie, Hadley, Melissa, Palmer, Erica, Austin, Paul Tran, Chisholm, Sarah, Diab, Noor, Roche, Kyle, Yu, Angela, Li, Jing, Zhu, Wenge, Lopez-Acevedo, Micael, Villagra, Alejandro, Chiappinelli, Katherine B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688520/ https://www.ncbi.nlm.nih.gov/pubmed/34931014 http://dx.doi.org/10.1038/s41598-021-04066-1

Ejemplares similares

Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
por: Moufarrij, Sara, et al.
Publicado: (2020)

Epigenetic therapy for ovarian cancer: promise and progress
por: Moufarrij, Sara, et al.
Publicado: (2019)

Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
por: Knox, Tessa, et al.
Publicado: (2019)

Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
por: Banik, Debarati, et al.
Publicado: (2019)

Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer
por: Gomez, Stephanie, et al.
Publicado: (2022)

Author Correction: DNMT3L enables accumulation and inheritance of epimutations in transgenic Drosophila
por: Basu, Amitava, et al.
Publicado: (2022)

The Role of DNMT and HDACs in the Fetal Programming of Hypertension by Glucocorticoids
por: Lamothe, J., et al.
Publicado: (2020)

Author Correction: HDAC3 inhibition ameliorates spinal cord injury by immunomodulation
por: Kuboyama, Tomoharu, et al.
Publicado: (2018)

Author Correction: DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons
por: Zhao, Jian-Yuan, et al.
Publicado: (2020)

Author Correction: NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes
por: Chen, Yng‑Tay, et al.
Publicado: (2021)

Author Correction: PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart
por: Yoon, Somy, et al.
Publicado: (2019)

Author Correction: Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis
por: Chen, Jizheng, et al.
Publicado: (2020)

Author Correction: [(11)C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2022)

HDAC inhibitors and their potential applications to glioblastoma therapy
por: Adamopoulou, Eleni, et al.
Publicado: (2013)

The anticancer effects of HDAC inhibitors require the immune system
por: West, Alison C, et al.
Publicado: (2014)

Sulforaphane Reverses the Expression of Various Tumor Suppressor Genes by Targeting DNMT3B and HDAC1 in Human Cervical Cancer Cells
por: Ali Khan, Munawwar, et al.
Publicado: (2015)

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
por: Berg, Hege F., et al.
Publicado: (2021)

Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
por: Knox, Tessa, et al.
Publicado: (2019)

Author Correction: Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin’s tumors
por: Tanaka, Fumine, et al.
Publicado: (2022)

Author Correction: Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
por: Kim, Sungsik, et al.
Publicado: (2018)

HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
por: Harada, Takeshi, et al.
Publicado: (2017)

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8(+) T-cell response and effective tumor control
por: Sun, Zhichen, et al.
Publicado: (2020)

Rapamycin: A rheostat for CD8(+) T-cell-mediated tumor therapy
por: Srivastava, Rupesh K., et al.
Publicado: (2012)

Author Correction: An antioxidant ameliorates allergic airway inflammation by inhibiting HDAC 1 via HIF-1α/VEGF axis suppression in mice
por: Islam, Ramiya, et al.
Publicado: (2023)

Authors’ reply
por: Raizada, Seemant, et al.
Publicado: (2015)

Author Correction: Fcmr regulates mononuclear phagocyte control of anti-tumor immunity
por: Kubli, Shawn P., et al.
Publicado: (2019)

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA
por: Kingston, Belinda, et al.
Publicado: (2021)

Author Correction: The role of tumor model in magnetic targeting of magnetosomes and ultramagnetic liposomes
por: Curcio, Alberto, et al.
Publicado: (2023)

Author Correction: Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis
por: Shao, Bin, et al.
Publicado: (2023)

Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines
por: Shirwan, Haval, et al.
Publicado: (2013)

Author Correction: Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model
por: Berrueta, L., et al.
Publicado: (2018)

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019)

Author Correction: Drug response in organoids generated from frozen primary tumor tissues
por: Walsh, Alex J., et al.
Publicado: (2019)

Author Correction: Impairing flow-mediated endothelial remodeling reduces extravasation of tumor cells
por: Follain, Gautier, et al.
Publicado: (2021)

Author Correction: Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
por: Schrand, Brett, et al.
Publicado: (2021)

Author Correction: Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma
por: Zhu, Yongxia, et al.
Publicado: (2022)

Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
por: Boshuizen, Julia, et al.
Publicado: (2023)

Author Correction: Accurate detection of circulating tumor DNA using nanopore consensus sequencing
por: Marcozzi, Alessio, et al.
Publicado: (2023)

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3
por: Concha-Benavente, Fernando, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lhrt636ofudcene558od33hl5l